FDAa

TissueGene, Inc. Announces FDA Acceptance Of Invossa™ As Proprietary Name For TissueGene-C

ROCKVILLE, Md., June 24, 2015 /PRNewswire/ —  TissueGene, Inc. today reported that the U.S. Food and Drug Administration (FDA) accepted the proposed…